Novel Anti-Sugar Chain Antibody and Use Thereof
Summary
The European Patent Office published patent EP4227413A1 for National University Corporation Chiba University, covering a novel anti-sugar chain antibody and its therapeutic applications. The patent addresses immunology treatments including A61P 37/00 and A61P 43/00. The publication designates multiple European states including DE, FR, GB, IT, NL, ES, and others. Inventors are Kawashima Hiroto and Matsumura Ryuji.
What changed
The EPO published patent application EP4227413A1 for Chiba University covering a novel anti-sugar chain antibody and its use. The invention falls under IPC classifications C07K 16/28 (immunoglobulins), C12N 15/13 (vector constructs), and C12P 21/08 (production methods), with therapeutic applications in immunological disorders.
Patent publications are informational records of granted intellectual property rights. Pharmaceutical companies developing antibody therapeutics should conduct freedom-to-operate analyses before commercializing similar products in designated EU states. No immediate compliance actions are required.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
NOVEL ANTI-SUGAR CHAIN ANTIBODY AND USE THEREOF
Publication EP4227413A1 Kind: A1 Mar 25, 2026
Applicants
National University Corporation Chiba University
Inventors
KAWASHIMA, Hiroto, MATSUMURA, Ryuji
IPC Classifications
C12N 15/13 20060101AFI20240917BHEP A61P 37/00 20060101ALI20240917BHEP A61P 43/00 20060101ALI20240917BHEP C07K 16/28 20060101ALI20240917BHEP C07K 16/46 20060101ALI20240917BHEP C12N 1/15 20060101ALI20240917BHEP C12N 1/19 20060101ALI20240917BHEP C12N 1/21 20060101ALI20240917BHEP C12N 5/10 20060101ALI20240917BHEP C12P 21/08 20060101ALI20240917BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.